Special considerations and pitfalls for intracerebral bleeding followed COVID-19 case treated by ECMO

COVID-19, or coronavirus infection, is an acute respiratory illness caused by the corona virus that can develop into a life-threatening form of ARDS. Extracorporeal membrane oxygenation (ECMO) is a highly effective treatment for life-threatening instances. One of the many complications associated wi...

Full description

Saved in:
Bibliographic Details
Published in:Brain hemorrhages 2024-02, Vol.5 (1), p.50-51
Main Authors: Amer, Wael Osman, El Gharieb, Hussein Awad, Ahmed, Zakaria, Ibrahim, Hossam, Alanazi, Ahmed, Meshref, Mostafa
Format: Article
Language:English
Subjects:
COVID-19
Dysregulated immune response
ECMO
Hypercoagulability
ICB
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:COVID-19, or coronavirus infection, is an acute respiratory illness caused by the corona virus that can develop into a life-threatening form of ARDS. Extracorporeal membrane oxygenation (ECMO) is a highly effective treatment for life-threatening instances. One of the many complications associated with ECMO was bleeding. COVID patients are at risk for intracerebral bleeding due to several factors, including the drug's action on ACE2 receptors, leading to hypertension, as well as hypercoagulability, dysregulated immune response, DIC, and the use of anticoagulants.
ISSN:2589-238X
2589-238X
DOI:10.1016/j.hest.2023.06.001